Cephalon plans to buy a generic drug maker based in Switzerland for $590 million, the...

With the defeat of Democrat Martha Coakley by Republican Scott Brown in the race to fill the seat of late Massachusetts Sen. Ted Kennedy, and the loss of the Democrats’ filibuster-proof majority in the Senate, the healthcare-reform bill stands on a knife’s edge. And how will pharmacies be reimbursed for dispensing generic drugs to Medicaid and Medicare patients if a health overhaul bill fails to pass? These topics, along with the issue of patent settlements vexing the branded and generic drug industries and a new GAO study showing that drug costs are soaring, are explored in depth in the latest installment of the ECRM Generics report.

The Food and Drug Administration has approved a generic version of a prescription laxative made...

In a letter to Rep. Stephen Lynch, D-Mass., the National Community Pharmacists Association’s chief executive...

Several drug makers and an industry trade group representing them will fund a two-year study...

Six governors are hoping to thwart an attempt by the Obama administration to eliminate language...

A licensed online pharmacy and a health insurer are collaborating to provide members with 90-day...

As the House and Senate fuse their respective healthcare-reform bills into one, a push has...

Two independent community pharmacy advocates are urging Congress to consider more practical alternatives to legislation...

Prices of 416 branded drugs dramatically rose between 2000 and 2008, according to a recent...

China can't be said to have retail pharmacies in the American sense because, under current...

Surescripts, the electronic prescribing company founded in 2001 by the National Association of Chain Drug...